Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia

The nasal epithelium is a key portal for infection by respiratory viruses such as SARS-CoV-2 and represents an important target for prophylactic and therapeutic interventions. In the present study, we test the safety and efficacy of a newly developed nasal spray (AM-301, marketed as Bentrio) against...

Descripción completa

Detalles Bibliográficos
Autores principales: Fais, Fabio, Juskeviciene, Reda, Francardo, Veronica, Mateos, Stéphanie, Guyard, Manuela, Viollet, Cécile, Constant, Samuel, Borelli, Massimo, Hohenfeld, Ilja P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999825/
https://www.ncbi.nlm.nih.gov/pubmed/35409423
http://dx.doi.org/10.3390/ijms23074062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999825/
https://www.ncbi.nlm.nih.gov/pubmed/35409423
http://dx.doi.org/10.3390/ijms23074062

Ejemplares similares